Here are relevant reports on : fuel-cell-marine-market
-
Flow Cytometry Market by Technology (Cell-based, Bead-Based), Product & Service (Analyzer, Sorter, Consumables (Antibodies, Assays, Kits), Software), Application (Research (Stem Cell), Clinical (Cancer)), End User (Hospital) - Global Forecast to 2033
The global flow cytometry market, valued at US$4.87 billion in 2024, stood at US$5.06 billion in 2025 and is projected to advance at a resilient CAGR of 8.7% from 2025 to 2033, culminating in a forecasted valuation of US$9.85 billion by the end of the period. The major factors driving the growth in the flow cytometry market include advancements in technology, increasing adoption of flow cytometry products in clinical diagnostics, rising prevalence of chronic diseases, growing biopharmaceutical R&D, and the need for precision medicine.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Cell Based Assays Market by Offering (Consumables (Reagents, Assay Kits, Cell Lines, Microplates, Probes, Labels), Instruments & Software), Technology (Flow Cytometry, HTS), Application (Drug Discovery (Toxicity, PK/PD Studies)) - Global Forecast to 2030
The global cell-based assays market, valued at US$17.36B in 2024, is forecasted to grow at a 9.1% CAGR, reaching US$18.134B by 2025 and US$25.77B by 2030. Growth in this market is primarily driven by the increasing demand for drug discovery and development, the increasing preference for cell-based assays in drug discovery, and the rising prevalence of cancer.
- Published: April 2025
- Price: $ 4950
- TOC Available:
-
Spray Polyurethane Foam Market by Type (Open-cell, and closed-cell), Product, Application (Insulation, Waterproofing, Roofing, Asbestos Encapsulation, Sealant, and Others), and Region - Global Forecast to 2030
The global spray polyurethane foam market is projected to grow from USD 2.4 billion in 2022 to USD 4.6 billion by 2030, at a CAGR of 8.3% during the forecast period. Increased usage of spray polyurethane foam in the construction sector is expected to drive the market during the forecast period.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Viral Inactivation Market by Product (Kits, Reagents, Systems, Services), Application (Stem Cell, Blood, Tissue, Cell & Gene Therapy), Method (Solvent Detergent, Pasteurization) & End User (Pharmaceutical and Biotechnology, CROs) - Global Forecast to 2021
The global viral inactivation market is segmented on the basis of method, product, application, end user, and geography. By method, the market is divided into solvent detergent method, pasteurization, and other methods. The global viral inactivation market was valued at USD 320.5 Million in 2016. This market is expected to grow at a CAGR of 12.3% to reach USD 573.0 Million in 2021.
- Published: June 2016
- Price: $ 4950
- TOC Available:
-
Cell Culture Market by Product (Consumables (Media, Sera, Reagent, Vessels (Roller bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), End User - Global Forecast to 2030
The global cell culture market, valued at US$27.92 billion in 2024, stood at US$29.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$50.69 billion by the end of the period. Growing opportunities in emerging economies and advancements in 2D and 3D cell culture technology is likely to offer potential growth opportunities in the cell culture market.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Stem Cell Therapy Market by Type (Allogeneic, Autologous), Cell Source (Adipose Tissue, Bone Marrow, Placenta/Umbilical Cord), Therapeutic Application (Musculoskeletal, Wounds, Surgeries, Inflammatory, Autoimmune, Cardiovascular) & Region - Global Forecast to 2028
The global stem cell therapy market, valued at US$259 million in 2022, stood at US$286 million in 2023 and is projected to advance at a resilient CAGR of 16.5% from 2023 to 2028, culminating in a forecasted valuation of US$615 million by the end of the period. Market growth is driven mainly by factors such as rise in funding for stem cell research, upsurge in the number of cell therapy production facilities that have GMP certification, and increased in the number of clinical trials associated with stem cell therapies.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Stem Cell Assays Market Size by Type (Viability, Proliferation, Differentiation, Apoptosis), Cell Type (Mesenchymal, iPSCs, HSCs, hESCs), Product & Service (Instrument), Application (Regenerative Medicine, Clinical Research), End User - Global Forecast to 2027
The size of global stem cell assays market in terms of revenue was estimated to be worth USD 1.9 billion in 2022 and is poised to reach USD 4.5 billion by 2027, growing at a CAGR of 17.7% from 2022 to 2027. The research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: June 2022
- Price: $ 4950
- TOC Available:
-
Track Etched Membrane Market by Product (Membrane Filter, Capsule & Cartridge Filter, Cell Culture Insert), Material (Polycarbonate, Polyimide), Application (Cell Biology, Microbiology, Analytical testing, Automotive), End User - Global Forecasts to 2023
The track etched membrane market is projected to reach USD 813.1 million by 2023, growing at a CAGR of 11.3%. Key players operating in the global track etched membrane are GE Healthcare (US), Danaher (US), Corning (US), Merck (Germany), it4ip (Belgium), Sterlitech (US), Oxyphen (Switzerland), Sarstedt (US), BRAND GMBH (Germany), Sartorius (Germany), SABEU (Germany), Zefon International (US), GVS (Italy), Thermo Fisher Scientific (US), Eaton (Ireland), Greiner Bio-One (Austria), MACHEREY-NAGEL (Germany), Avanti Lipids Polar (US), SKC (US), Advantec (Canada), Avestin (Canada), Scaffdex (Finland), and Graver Technologies (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Cartilage Repair Market | Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-Cell (Tissue Scaffolds)), Application (Hyaline, Fibrocartilage), Site, and Region - Global Forecast to 2028
The global cartilage repair market, valued at US$1.1 billion in 2022, stood at US$1.3 billion in 2023 and is projected to advance at a resilient CAGR of 17.2% from 2023 to 2028, culminating in a forecasted valuation of US$2.8 billion by the end of the period. Growth in this market is mainly driven by the Increasing incidence of osteoarthritis, Increasing research funding and investments and the rising number of sports and accident-related orthopedic injuries.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Europe Cell Culture Market by Product [Consumable {Media, Sera, Reagent, Vessel (Roller Bottle, Flask, Cell Factory)}, Equipment {Bioreactor, Centrifuge, Filtration, Incubator, Freezer}], Application [mAb, Vaccine, CGT], End User - Forecast to 2030
The Europe Cell Culture Market, valued at US$8.01 billion in 2024, stood at US$8.50 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$14.23 billion by the end of the period. The growth of the Europe cell culture market is driven by a strong and expanding biopharmaceutical sector, with rising production of biologics such as monoclonal antibodies, vaccines, and recombinant proteins that rely on sophisticated culture systems.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
